Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Protocols

Protocols

EDRN investigators protocols. The following is a list of the EDRN protocols that have been captured and curated. Additional information will be added as it is available. Contact information is provided as part of the detail for each protocol.

Contents

Title Abstract Investigator
A Methylation Panel for Bladder Cancer Gazdar, Adi
A comparison of cytology and fluorescence in situ hybridization for the detection of lung cancer in bronchoscopic specimens To determine the relative sensitivity and specificity of cytology and fluorescence in situ hybridization (FISH) for the detection of lung cancer in ... Halling, Kevin C
A prediction model for lung cancer diagnosis that integrates genomic and clinical features. Lung cancer is the leading cause of cancer death due, in part, to lack of early diagnostic tools. Bronchoscopy represents a relatively noninvasive initial ... Beane, Jennifer
Affinity-based strategies to fast track development of colon cancer biomarkers Our goal is to discover plasma and tissue-based tumor biomarkers that work well enough together to identity colon cancer at early stages, lead to accurate ... Lampe, Paul
Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer. Lung cancer is the leading cause of death from cancer in the US and the world. The high mortality rate (80-85% within 5 years) results, in part, from a lack of ... Spira, Avrum
Antibodies Against Tumor Antigens or Mucin Epitopes in Ovarian Cancer Cramer, Daniel
Assessment of Clinical Potential of Digital SNP Analysis Helzlsouer, Kathy
Aurora Kinase A as a Biomarker for the Detection of Bladder Cancer - Supplemental Pre-Validation Protocol Czerniak, Bogdan
Autoantibodies in lung cancer: possibilities for early detection and subsequent cure. BACKGROUND: People with lung cancer usually present at a late stage in the course of their disease when their chances of long-term survival are low. At ... Chapman, Caroline J.
Autoantibody Approach for Serum-Based Detection of Head and Neck Cancer Our long term goal is to improve survival of patients with head and neck squamous cell carcinoma (HNSCC) through early detection using simple noninvasive serum ... Tainsky, Michael A.
BBD Reference Set Application: Jeffery Marks (2015) Marks, Jeffrey
BBD Reference Set Application: Jeffery Marks-Duke (2015) Marks, Jeffrey
BRSCW Applicant: Buechler - Biosite Inc (2009) Over 40 marker assays are available to run on the samples. These include markers such as Osteopontin, Mesothelin, Periostin, Endoglin, intestinal Fatty Acid ... Buechler, Joe
BRSCW Applicant: Diamandis - Mt Sinai (2006) Examine kallikreins as ovarian cancer biomarkers and determine sensitivity and specificity of panel Diamandis, Eleftherios P.
BRSCW Applicant: Abbott 2014 Our earlier glycoproteomic studies have identified bisecting glycoslyation and core fucosylation changes on particular glycoproteins in endometrioid ovarian ... Abbott, Karen
BRSCW Applicant: Morre - NOX Technologies Inc. (2009) Evaluation using NOX Technologies ECTO-NOX blot diagnostic 2-D gel electrophoretic cancer detection system in combination with a sandwich ELISA of our ... Morre, D. James
BRSCW Applicant: Wilson - EIC Laboratories, Inc (2007) Samples were returned unused. Analysis never completed. Wilson, Michael S.
BRSCW Ref Set Application: Anna Lokshin - Univ of Pitts (2008) Validate biomarkers identified using Luminex bead-based arrays in case/control sets (individual samples) in reference sets Lokshin, Anna
BRSCW Reference Set Application: Anu Mathew - Meso Scale (2006) Mathew, Anu
BRSCW Reference Set Application: Eleftherios Diamandis - Mt Sinai (2006) Examine kallikreins as ovarian cancer biomarkers Diamandis, Eleftherios P.
BRSCW Reference Set Application: GeorgeTuszynski - Temple University (2012) Tuszynski, George
BRSCW Reference Set Application: James Morre - NOX Technologies Inc. (2009) Evaluation using NOX Technologies ECTO-NOX blot diagnostic 2-D gel electrophoretic cancer detection system in combination with a sandwich ELISA of our ... Morre, D. James
BRSCW Reference Set Application: Joe Buechler - Biosite Inc (2009) Over 40 marker assays are available to run on the samples. These include markers such as Osteopontin, Mesothelin, Periostin, Endoglin, intestinal Fatty Acid ... Buechler, Joe
BRSCW Reference Set Application: Karen Abbott -University of Arkansas (2014) Our earlier glycoproteomic studies have identified bisecting glycoslyation and core fucosylation changes on particular glycoproteins in endometrioid ovarian ... Abbott, Karen
BRSCW Reference Set Application: Michael Birrer-Massachusetts General Hospital (2013) Validate FGF18 and GPR172A in reference set Birrer, Michael
BRSCWRef Set Application: Michael Wilson - EIC Laboratories, Inc (2007) The selected markers are well established as "standard" markers fo ra range of cancers, and have been analyzed in the reference set as a benchmark for ... Wilson, Michael S.
Barrett's Esophagus Methylation Profiles We propose a nested case-control study of biomarkers in the setting of BE. By bringing together research institutions with large populations of patients with ... Meltzer, Stephen
Basophile: Accurate Fragment Charge State Prediction Improves Peptide Identification Rates In shotgun proteomics, database search algorithms rely on fragmentation models to predict fragment ions that should be observed for a given peptide sequence. ... Wang, Dong
Benign Breast Disease Team Project To identify women diagnosed with atypical ductal hyperplasia (ADH) who are at increased risk of developing invasive breast cancer (IBC) and who might benefit ... Engstrom, Paul
Biomarker Detection Using NAPPA Tumor Antigen Arrays Cancer patients spontaneously generate autoantibodies (AAb) to tumor-derived proteins. To detect AAb, we have probed novel high-density custom protein ... LaBaer, Joshua
2015 EDRN PI Orientation

The New and Continuing EDRN Principal Investigator Orientation will take place October 15–16, 2015 in Bethesda, Maryland.

Announcement 04/08/2015

Thank you to everyone who made the 29th EDRN Steering Committee Meeting a success. The orientation for new and continuing EDRN PIs will be held October 15-16, 2015 on the NCI campus. More information will be available later this summer.

Announcement